Psoriasis

In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the recently approved interleukin-17 inhibitor bimekizumab from the Maui Derm 2024 meeting, examining its use in treating psoriasis.

In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the oral molecule apremilast from the Maui Derm 2024 meeting, examining the SPROUT study into apremilast’s use treating psoriasis.

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses racial and gender disparities that exist in psoriasis care.

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses risk factors for psoriasis.

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses treatments in the pipeline for psoriasis.

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses the unmet needs of patients with psoriasis.

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses the latest treatment advancements for psoriasis.

The use of biologics to treat psoriasis does not affect antibody production after a patient has had a COVID infection or vaccination, according to a study.

Pediatric patients with psoriasis experienced significant improvement with oral apremilast treatment, according to phase 3 trial results.

Patients with skin of color that suffer from scalp psoriasis saw significant improvement in their disease severity, scalp itch and quality of life outcomes when treated with Tremfya, according to newly released phase 3 results.